Expert Insights: Strategies for Step-Up Dosing and Long-Term Treatment Management with Bispecifics in R/R MM

Opinion
Video

Experts on multiple myeloma provide comprehensive insights on treatment spacing and step-up dosing practices and discuss the long-term utilization of bispecific antibodies.

Video content above is prompted by the following questions:

  • How are the step-up and treatment doses for bispecifics administered at your institution? Are they administered in your clinic or in the community?
    • How are patients monitored for CRS and ICANS during step-up dosing?

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
The dual high-affinity binding observed with ISB 2001 may avoid resistance mechanisms reported with other BCMA-targeted therapies.
Related Content